Nijagal Amar, Le Tom, Wegorzewska Marta, Mackenzie Tippi C
Department of Surgery, University of California, USA.
J Vis Exp. 2011 Jan 27(47):2303. doi: 10.3791/2303.
The transplantation of stem cells and viruses in utero has tremendous potential for treating congenital disorders in the human fetus. For example, in utero transplantation (IUT) of hematopoietic stem cells has been used to successfully treat patients with severe combined immunodeficiency. In several other conditions, however, IUT has been attempted without success. Given these mixed results, the availability of an efficient non-human model to study the biological sequelae of stem cell transplantation and gene therapy is critical to advance this field. We and others have used the mouse model of IUT to study factors affecting successful engraftment of in utero transplanted hematopoietic stem cells in both wild-type mice and those with genetic diseases. The fetal environment also offers considerable advantages for the success of in utero gene therapy. For example, the delivery of adenoviral, adeno-associated viral, retroviral, and lentiviral vectors into the fetus has resulted in the transduction of multiple organs distant from the site of injection with long-term gene expression. in utero gene therapy may therefore be considered as a possible treatment strategy for single gene disorders such as muscular dystrophy or cystic fibrosis. Another potential advantage of IUT is the ability to induce immune tolerance to a specific antigen. As seen in mice with hemophilia, the introduction of Factor IX early in development results in tolerance to this protein. In addition to its use in investigating potential human therapies, the mouse model of IUT can be a powerful tool to study basic questions in developmental and stem cell biology. For example, one can deliver various small molecules to induce or inhibit specific gene expression at defined gestational stages and manipulate developmental pathways. The impact of these alterations can be assessed at various timepoints after the initial transplantation. Furthermore, one can transplant pluripotent or lineage specific progenitor cells into the fetal environment to study stem cell differentiation in a non-irradiated and unperturbed host environment. The mouse model of IUT has already provided numerous insights within the fields of immunology, and developmental and stem cell biology. In this video-based protocol, we describe a step-by-step approach to performing IUT in mouse fetuses and outline the critical steps and potential pitfalls of this technique.
子宫内干细胞和病毒移植在治疗人类胎儿先天性疾病方面具有巨大潜力。例如,造血干细胞的子宫内移植(IUT)已被用于成功治疗重症联合免疫缺陷患者。然而,在其他几种情况下,IUT尝试并未成功。鉴于这些喜忧参半的结果,拥有一个高效的非人类模型来研究干细胞移植和基因治疗的生物学后遗症对于推动该领域的发展至关重要。我们和其他人已经使用IUT小鼠模型来研究影响野生型小鼠和患有遗传疾病小鼠子宫内移植造血干细胞成功植入的因素。胎儿环境对于子宫内基因治疗的成功也具有相当大的优势。例如,将腺病毒、腺相关病毒、逆转录病毒和慢病毒载体递送至胎儿已导致远离注射部位的多个器官发生转导,并实现长期基因表达。因此,子宫内基因治疗可被视为治疗单基因疾病(如肌肉萎缩症或囊性纤维化)的一种可能治疗策略。IUT的另一个潜在优势是能够诱导对特定抗原的免疫耐受。如在血友病小鼠中所见,在发育早期引入凝血因子IX会导致对该蛋白产生耐受。除了用于研究潜在的人类疗法外,IUT小鼠模型还可以成为研究发育和干细胞生物学基本问题的有力工具。例如,可以递送各种小分子以在特定妊娠阶段诱导或抑制特定基因表达,并操纵发育途径。这些改变的影响可以在初次移植后的不同时间点进行评估。此外,可以将多能或谱系特异性祖细胞移植到胎儿环境中,以在未受辐射和未受干扰的宿主环境中研究干细胞分化。IUT小鼠模型已经在免疫学、发育和干细胞生物学领域提供了许多见解。在这个基于视频的方案中,我们描述了在小鼠胎儿中进行IUT的逐步方法,并概述了该技术的关键步骤和潜在陷阱。